🌿 Environment Jun 12, 2026 · Susan Kelly

Penumbra’s FDA nod for clot removal tech a win for Boston Scientific

MedTech Dive
MedTech industry news
View Channel →
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific
Source ↗ 👁 6 💬 0
The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.

Comments (0)

Sign in to join the discussion

More Like This

Summer break – ThinkGeoEnergy to come back on 21 July 2026
ThinkGeoEnergy – Geothermal News & Insights · Jul 7, 2026
From potential to execution: Looking back at the World Geothermal Congress 2026
ThinkGeoEnergy – Geothermal News & Insights · Jul 6, 2026
ThinkGeoEnergy enters a new chapter with website refresh
ThinkGeoEnergy – Geothermal News & Insights · Jul 6, 2026
Husum, Germany to undertake feasibility study for geothermal heating project
ThinkGeoEnergy – Geothermal News & Insights · Jul 6, 2026
Preparatory work on Geothermal Frontier Project sites in Japan to start this year
ThinkGeoEnergy – Geothermal News & Insights · Jul 6, 2026
Carrying on the legacy of geothermal innovation at the Utah FORGE project
ThinkGeoEnergy – Geothermal News & Insights · Jul 5, 2026